First Baby Born in Brazil after Simultaneous Diagnosis through Non-Invasive and Conventional PGT-A

Abstract

Non-invasive preimplantation genetic testing for aneuploidies (niPGT-A) aiming to assess cell-free embryonic DNA in spent culture media is promising, especially because it might overcome the diminished rates of implantation caused by the inadequate performance of trophectoderm (TE) biopsy. Our center is part of the largest study to date assessing the concordance between conventional PGT-A and niPGT-A, and we report here the delivery of the first baby born in Brazil using niPGT-A. The parents of the baby were admitted to our center in 2018. They did not present history of infertility, and they were interested in using in vitro fertilization (IVF) and PGT-A in order to avoid congenital anomalies in the offspring. A total of 11 (3 day-5 and 8 day-6) expanded blastocysts were biopsied, and the spent culture media (culture from day-4 to day-6) from 8 day-6 blastocysts were collected for niPGT-A. Overall, 7 embryos yielded informative results for trophectoderm (TE) and media samples. Among the embryos with informative results, 5 presented concordant diagnosis between conventional PGT-A and niPGT-A, and 2 presented discordant diagnosis (1 false-positive and one false-negative). The Blastocyst 4, diagnosed as 46, XY by both niPGT-A and conventional PGT-A, was warmed up and transferred, resulting in the birth of a healthy 3.8 kg boy in February 2020. Based on our results and the recent literature, we believe that the safest current application of niPGT-A would be as a method of embryo selection for patients without an indication for conventional PGT-A. The approximate 80% of reliability of niPGT-A in the diagnosis of ploidy is superior to predictions provided by other non-invasive approaches like morphology and morphokinetics selection.

Resumo

Abordagens para o teste genético pré-implantacional não-invasivo para aneuploidias (non-invasive preimplantation genetic testing for aneuploidies, niPGT-A, em inglês) com o objetivo de avaliar o DNA embrionário livre são promissoras, especialmente porque estas podem reverter as menores taxas de implantação causadas por inadequada biópsia de trofectoderma (TE). Nesse contexto, nosso centro é parte do maior estudo atual que avalia as taxas de concordância entre PGT-A convencional e niPGT-A, e relatamos aqui o nascimento do primeiro bebê brasileiro após niPGT-A. Os pais do bebê foram admitidos no nosso centro em 2018. Eles não apresentavam histórico de infertilidade, e estavam interessados em utilizar os tratamentos de fertilização in vitro (FIV) e PGT-A para evitar anomalias congênitas na progênie. Um total de 11 blastocistos expandidos (3 do dia-5 e 8 do dia-6) foram submetidos a biópsia, e os meios de cultivo condicionados (cultivo do dia-4 ao dia-6) de 8 blastocistos do dia-6 foram coletados para niPGT-A. No total, resultados informativos para as amostras de TE e dos meios foram obtidos para sete embriões. Entre os embriões com resultado informativo, 5 apresentaram diagnóstico concordante entre PGT-A convencional e niPGT-A, e 2 apresentaram diagnóstico discordante (1 falso positivo e 1 falso negativo). O Blastocisto 4, diagnosticado como 46, XY por ambos niPGT-A e PGT-A convencional, foi desvitrificado e transferido, o que resultou no nascimento de um menino saudável, que pesava 3,8 kg, em fevereiro de 2020. Com base em nossos resultados e literatura contemporânea, acreditamos que a aplicação atual mais segura do niPGT-A seria como método de seleção embrionária para pacientes sem indicação ao PGT-A convencional. A confiabilidade aproximada de 80% do niPGT-A para determinação da ploidia ainda é superior àquela obtida com abordagens não invasivas, como seleção morfológica ou morfocinética.

Keywords

niPGT-A - spent culture media - PGT-A - trophectoderm biopsy - blastocyst

Palavras-chave

niPGT-A - meio de cultivo condicionado - PGT-A - biópsia de trofectoderma - blastocisto

Publication History

Received: 07 December 2020

Accepted: 30 August 2021

Article published online:
06 December 2021

• References

• 1 Hornstein MD. State of the ART: assisted reproductive technologies in the United States. Reprod Sci 2016; 23 (12) 1630-1633 DOI: 10.1177/1933719116667227.
• 2 Cimadomo D, Fabozzi G, Vaiarelli A, Ubaldi N, Ubaldi FM, Rienzi L. Impact of maternal age on oocyte and embryo competence. Front Endocrinol (Lausanne) 2018; 9: 327 DOI: 10.3389/fendo.2018.0032.
• 3 Forman EJ, Tao X, Ferry KM, Taylor D, Treff NR, Scott Jr RT. Single embryo transfer with comprehensive chromosome screening results in improved ongoing pregnancy rates and decreased miscarriage rates. Hum Reprod 2012; 27 (04) 1217-1222 DOI: 10.1093/humrep/des020.
• 4 Dahdouh EM, Balayla J, García-Velasco JA. Comprehensive chromosome screening improves embryo selection: a meta-analysis. Fertil Steril 2015; 104 (06) 1503-1512 DOI: 10.1016/j.fertnstert.2015.08.038.
• 5 Neal SA, Morin SJ, Franasiak JM, Goodman LR, Juneau CR, Forman EJ. et al. Preimplantation genetic testing for aneuploidy is cost-effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage. Fertil Steril 2018; 110 (05) 896-904 DOI: 10.1016/j.fertnstert.2018.06.021.
• 6 Greco E, Minasi MG, Fiorentino F. Healthy babies after intrauterine transfer of mosaic aneuploid blastocysts. N Engl J Med 2015; 373 (21) 2089-2090 DOI: 10.1056/NEJMc1500421.
• 7 Fragouli E, Alfarawati S, Spath K, Babariya D, Tarozzi N, Borini A. et al. Analysis of implantation and ongoing pregnancy rates following the transfer of mosaic diploid-aneuploid blastocysts. Hum Genet 2017; 136 (07) 805-819 DOI: 10.1007/s00439-017-1797-4.
• 8 Neal SA, Franasiak JM, Forman EJ, Werner MD. High relative deoxyribonucleic acid content of trophectoderm biopsy adversely affects pregnancy outcomes. Fertil Steril 2017; 107 (03) 731-736.e1 DOI: 10.1016/j.fertnstert.2016.11.013.
• 9 Zhang S, Luo K, Cheng D, Tan Y, Lu C, He H. et al. Number of biopsied trophectoderm cells is likely to affect the implantation potential of blastocysts with poor trophectoderm quality. Fertil Steril 2016; 105 (05) 1222-1227.e4 DOI: 10.1016/j.fertnstert.2016.01.011.
• 10 Xu J, Fang R, Chen L, Xiao J, Yang W. et al. Noninvasive chromosome screening of human embryos by genome sequencing of embryo culture medium for in vitro fertilization. Proc Natl Acad Sci U S A 2016; 113 (42) 11907-11912 DOI: 10.1073/pnas.1613294113.
• 11 Feichtinger M, Vaccari E, Carli L, Wallner E, Mädel U, Figl K. et al. Non-invasive preimplantation genetic screening using array comparative genomic hybridization on spent culture media: a proof-of-concept pilot study. Reprod Biomed Online 2017; 34 (06) 583-589 DOI: 10.1016/j.rbmo.2017.03.015.
• 12 Vera-Rodriguez M, Diez-Juan A, Jimenez-Almazan J, Martinez S, Navarro R, Peinado V. et al. Origin and composition of cell-free DNA in spent medium from human embryo culture during preimplantation development. Hum Reprod 2018; 33 (04) 745-756 DOI: 10.1093/humrep/dey028.
• 13 Yeung QSY, Zhang YX, Chung JPW, Lui WT, Kwok YK, Gui B. et al. A prospective study of non-invasive preimplantation genetic testing for aneuploidies (NiPGT-A) using next-generation sequencing (NGS) on spent culture media (SCM). J Assist Reprod Genet 2019; 36 (08) 1609-1621 DOI: 10.1007/s10815-019-01517-7.
• 14 Ho JR, Arrach N, Rhodes-Long K, Ahmady A, Ingles S, Chung K. et al. Pushing the limits of detection: investigation of cell-free DNA for aneuploidy screening in embryos. Fertil Steril 2018; 110 (03) 467-475.e2 DOI: 10.1016/j.fertnstert.2018.03.036.
• 15 Huang L, Bogale B, Tang Y, Lu S, Xie XS, Racowsky C. Noninvasive preimplantation genetic testing for aneuploidy in spent medium may be more reliable than trophectoderm biopsy. Proc Natl Acad Sci U S A 2019; 116 (28) 14105-14112 DOI: 10.1073/pnas.1907472116.
• 16 Rubio C, Rienzi L, Navarro-Sánchez L, Cimadomo D, García-Pascual CM, Albricci L. et al. Embryonic cell-free DNA versus trophectoderm biopsy for aneuploidy testing: concordance rate and clinical implications. Fertil Steril 2019; 112 (03) 510-519 DOI: 10.1016/j.fertnstert.2019.04.038.
• 17 Rubio C, Navarro-Sánchez L, García-Pascual CM, Ocali O, Cimadomo D, Venier W. et al. Multicenter prospective study of concordance between embryonic cell-free DNA and trophectoderm biopsies from 1301 human blastocysts. Am J Obstet Gynecol 2020; 223 (05) 751.e1-751.e13 DOI: 10.1016/j.ajog.2020.04.035.
• 18 Capalbo A, Rienzi L, Cimadomo D, Maggiulli R, Elliott T, Wright G. et al. Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts. Hum Reprod 2014; 29 (06) 1173-1181 DOI: 10.1093/humrep/deu033.
• 19 Shapiro BS, Richter KS, Harris DC, Daneshmand ST. A comparison of day 5 and day 6 blastocyst transfers. Fertil Steril 2001; 75 (06) 1126-1130 DOI: 10.1016/s0015-0282(01)01771-x.
• 20 Barrenetxea G, López de Larruzea A, Ganzabal T, Jiménez R, Carbonero K, Mandiola M. Blastocyst culture after repeated failure of cleavage-stage embryo transfers: a comparison of day 5 and day 6 transfers. Fertil Steril 2005; 83 (01) 49-53 DOI: 10.1016/j.fertnstert.2004.06.049.
• 21 Haas J, Meriano J, Laskin C, Bentov Y, Barzilay E, Casper RF. et al. Clinical pregnancy rate following frozen embryo transfer is higher with blastocysts vitrified on day 5 than on day 6. J Assist Reprod Genet 2016; 33 (12) 1553-1557 DOI: 10.1007/s10815-016-0818-x.
• 22 Tubbing A, Shaw-Jackson C, Ameye L, Colin J, Rozenberg S, Autin C. Increased live births after day 5 versus day 6 transfers of vitrified-warmed blastocysts. J Assist Reprod Genet 2018; 35 (03) 417-424 DOI: 10.1007/s10815-017-1097-x.
• 23 Kaing A, Kroener LL, Tassin R, Li M, Liu L, Buyalos R. et al. Earlier day of blastocyst development is predictive of embryonic euploidy across all ages: essential data for physician decision-making and counseling patients. J Assist Reprod Genet 2018; 35 (01) 119-125 DOI: 10.1007/s10815-017-1038-8.
• 24 Sciorio R, Thong KJ, Pickering SJ. Increased pregnancy outcome after day 5 versus day 6 transfers of human vitrified-warmed blastocysts. Zygote 2019; 27 (05) 279-284 DOI: 10.1017/S0967199419000273.
• 25 Tiegs AW, Sun L, Patounakis G, Scott RT. Worth the wait? Day 7 blastocysts have lower euploidy rates but similar sustained implantation rates as Day 5 and Day 6 blastocysts. Hum Reprod 2019; 34 (09) 1632-1639 DOI: 10.1093/humrep/dez138.
• 26 Irani M, O'Neill C, Palermo GD, Xu K, Zhang C, Qin X. et al. Blastocyst development rate influences implantation and live birth rates of similarly graded euploid blastocysts. Fertil Steril 2018; 110 (01) 95-102.e1 DOI: 10.1016/j.fertnstert.2018.03.032.
• 27 Minasi MG, Colasante A, Riccio T, Ruberti A, Casciani V, Scarselli F. et al. Correlation between aneuploidy, standard morphology evaluation and morphokinetic development in 1730 biopsied blastocysts: a consecutive case series study. Hum Reprod 2016; 31 (10) 2245-2254 DOI: 10.1093/humrep/dew183.
• 28 Reignier A, Lammers J, Barriere P, Freour T. Can time-lapse parameters predict embryo ploidy? A systematic review. Reprod Biomed Online 2018; 36 (04) 380-387 DOI: 10.1016/j.rbmo.2018.01.001.